glp 1 agonists review GLP-1 For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH How GLP-1 Receptor Agonists Evolved

For patients with severe obesity and metabolic disease, this is a giftlife-extending, even lifesaving

GLP-1 has a short half-life of only two minutes, due to renal clearance and endogenous GLP-1 is degraded by the enzyme dipeptidyl peptidase IV (DPP-4) (2022)

In the early stages, a strategy of starting exenatide with a lower than maintenance dose, slowly increasing to the desired steady state, was found to reduce problems with gastrointestinal adverse events

VrintsCAndreottiFKoskinasKCRosselloXAdamoMAinslieJet al2024 ESC guidelines for the management of chronic coronary syndromes

2018;20(S2):13744

As a result, it improves A1C and supports meaningful weight loss